Jan 09, 2024 / 06:30PM GMT
Richard Vosser - JPMorgan Chase & Co, Research Division - Senior Analyst
Welcome to the Sanofi presentation at the 42nd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. It's my great pleasure to introduce Paul Hudson, the CEO of Sanofi here. Before I hand over to Paul, just to remind you that if you put your hand up for questions when we get to the Q&A period. Paul, welcome to the conference.
Paul Hudson - Sanofi - CEO & Director
Okay. Thank you. Thank you, Richard. Good morning, good afternoon. What a warm introduction, Richard. Great job. Really got me in the spirit of things. Fortunately, my content is good. You'll decide. No, it's fine. It's fine. So it's a great pleasure for me to be here, to be sharing a little bit about what's going on at Sanofi. It's a real moment for the company. And we're very excited about what we're becoming and it's good to share it because it's been a long time in the making and we really feel like we're demonstrating that with the new Sanofi.
Maybe I'll start with this,
Sanofi SA at JPMorgan Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers